	Methylation status of GSTP1 and APC promoter genes as potential biomarkers for early detection and tumor aggressiveness in prostate cancer: insights from a Moroccan cohort. Mol Biol Rep Mharrach I, Aqerrout M, Tadlaoui KA, Laraqui A, Ghazzaly AE, Ennaji MM. PMID: 40663294 [PubMed - indexed for MEDLINE]
	RETRACTION: Upregulation of mTORC2 Activation by the Selective Agonist of EPAC, 8-CPT-2Me-cAMP, in Prostate Cancer Cells: Assembly of a Multiprotein Signaling Complex. J Cell Biochem PMID: 40662287 [PubMed]
	RETRACTION: Loss of Cell Surface TFII-I Promotes Apoptosis in Prostate Cancer Cells Stimulated With Activated Î±2-Macroglobulin. J Cell Biochem PMID: 40662283 [PubMed]
	RETRACTION: Epac1-Induced Cellular Proliferation in Prostate Cancer Cells Is Mediated by B-Raf/ERK and mTOR Signaling Cascades. J Cell Biochem PMID: 40662249 [PubMed]
	Intravesical Disitamab Vedotin (RC48) for HER2-Expressing High-Risk Non-Muscle-Invasive Bladder Cancer: A Single-Arm, Dose-Escalation Phase I Trial Study. MedComm (2020) Chen X, Huang M, Chen Z, Zhang C, Pan B, Liu C, Xu W, Fang J, Huang J, Lin T. PMID: 40661136 [PubMed]
	Copper death combination therapy: the innovative frontier and challenges in prostate cancer treatment. Cancer Biol Ther He JW, Li PZ, Huang ZX. PMID: 40660923 [PubMed - indexed for MEDLINE]
	Evaluation of multileaf collimator driving accuracy in helical rotational irradiation system: Quantitative analysis of leaf open time during treatment. J Appl Clin Med Phys Honda H, Sasaki M, Tominaga M, Omoto K, Kido T. PMID: 40660897 [PubMed - indexed for MEDLINE]
	Diagnostic value of 18F-prostate-specific membrane antigen-1007 PET/MRI versus 18F-prostate-specific membrane antigen-1007 PET/computed tomography for biochemical recurrence of prostate cancer after radical prostatectomy. Nucl Med Commun Zeng Y, Liao H, Jiang G, Wu G, Zhong J. PMID: 40660863 [PubMed - as supplied by publisher]
	Noninterventional retrospective study of standard-of-care systemic treatment patterns and outcomes in US patients with advanced urothelial carcinoma. Oncologist Moon HH, Kirker M, Abraham A, Vlahiotis A, Bhanegaonkar A, Ike C, Benjumea D, Kim C, Sun H, Kearney M, Chandrasekar S, Li B, Thakkar S. PMID: 40660677 [PubMed - indexed for MEDLINE]
	How to Support Participants in Urogenital and Prostate Clinical Trials: A Qualitative Perspective. Psychooncology Roberts NA, Davis ID, Wyld D, Goh J, Thompson M, Gedye C, Dhillon HM. PMID: 40660614 [PubMed - indexed for MEDLINE]
	Linking 91 inflammatory cytokines to testicular cancer through metabolites: An exploratory two-step Mendelian randomization study. Medicine (Baltimore) Wang XX, Zhu KF. PMID: 40660557 [PubMed - indexed for MEDLINE]
	Clinical value of transperineal prostate biopsy guided by cognitive fusion of magnetic resonance and transrectal ultrasound. Medicine (Baltimore) Zhao F, Zhang K, Huang Y. PMID: 40660556 [PubMed - indexed for MEDLINE]
	A possible role of urinary genotoxic Escherichia coli in prostate cancer in Nigerian patients. BMC Res Notes Akinpelu SO, Olasehinde GI, Akinnola OO. PMID: 40660394 [PubMed - indexed for MEDLINE]
	Integrating anamnestic and lifestyle data with sphingolipid levels for risk-based prostate cancer screening. J Transl Med Peraldo-Neia C, Ostano P, Savioli M, Mello-Grand M, Gregnanin I, Guana F, Crivelli F, Montagnani F, Dei-Cas M, Paroni R, Sinopoli A, Ferranti F, Testino N, Oderda M, Zitella A, Fiameni C, Gagliardi A, Naccarati A, Clivio L, Gontero P, Zaramella S, Chiorino G. PMID: 40660231 [PubMed - indexed for MEDLINE]
	Assessing the clinical outcomes of immunotherapy and docetaxel combinations in metastatic castration-resistant prostate cancer: a meta-analysis. BMC Cancer Syed A, Raza H, Khaskheli HK, Rafique I, Shahid S, Shahzadi N, Al Komi AS, Assiri AA, Khokhar MA, Khan NU. PMID: 40660223 [PubMed - indexed for MEDLINE]
	Advancing prostate cancer research: an exploration of periprostatic adipose stem cells. J Transl Med Sacca PA, Calvo JC. PMID: 40660195 [PubMed - indexed for MEDLINE]
	Barriers and facilitators to accessing healthcare for early diagnosis of prostate cancer for black men-a qualitative exploration in North-East England and Scotland. BMC Public Health Christie-de Jong F, Oyeniyi OS, Nnyanzi LA, Ling J, Murphy MK, Eberhardt J, Jarrar R, Kabuye J, Kalemba M, Robb KA. PMID: 40660194 [PubMed - indexed for MEDLINE]
	Microwave ablation versus combined microwave ablation and transarterial chemoembolization for T1a renal cell carcinoma: a Single-Center retrospective study. BMC Urol Erdim Ç, Solak S, Türkcano, Arslan MF, K. PMID: 40660192 [PubMed - in process]
	Radical nephrectomy with inferior vena caval thrombectomy for level I to IV tumor thrombus: long-term single-center experience. BMC Urol Navratil P, Chalupnik J, Louda M, Habal P, Zacek P, Brodak M, Pacovsky J. PMID: 40660155 [PubMed - indexed for MEDLINE]
	The efficacy and safety of enzalutamide in metastatic hormone-sensitive prostate cancer: a meta-analysis based on subgroups and reconstructed individual patient data. Int Urol Nephrol Zhang F, Luo Z, Xue Q, Guo X, Fu Q, Jiao Y, Zhang W, Xiong Y, Alisha PA, Okoli UA, Zhang G. PMID: 40660075 [PubMed - as supplied by publisher]

Articles 1 - 20 / 168816

Page 1 of 8441



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy